Real-World Use of Fingolimod in Patients with Relapsing Remitting Multiple Sclerosis: A Retrospective Study Using the National Multiple Sclerosis Registry in Kuwait

被引：0
|
作者：
Jasem AL-Hashel
Samar F. Ahmed
Raed Behbehani
Raed Alroughani
机构：
[1] Ibn Sina Hospital,Department of Neurology
[2] Kuwait University,Faculty of Medicine
[3] Minia University,Department of Neurology and Psychiatry
[4] Al-Bahar Eye Center,Department of Ophthalmology
[5] Dasman Diabetes Institute,Neurology Clinic
[6] Amiri Hospital,Division of Neurology, Department of Medicine
来源：
CNS Drugs | 2014年 / 28卷
关键词：
Multiple Sclerosis; Expand Disability Status Scale; Natalizumab; Glatiramer Acetate; Fingolimod;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：817 / 824
页数：7
相关论文
共 50 条
  • [1] Real-World Use of Fingolimod in Patients with Relapsing Remitting Multiple Sclerosis: A Retrospective Study Using the National Multiple Sclerosis Registry in Kuwait
    AL-Hashel, Jasem
    Ahmed, Samar F.
    Behbehani, Raed
    Alroughani, Raed
    CNS DRUGS, 2014, 28 (09) : 817 - 824
  • [2] Use of fingolimod in patients with relapsing remitting multiple sclerosis in Kuwait
    Alroughani, R.
    Ahmed, S. F.
    Behbehani, R.
    Al-Hashel, J.
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2014, 119 : 17 - 20
  • [3] Effectiveness of fingolimod in real-world relapsing-remitting multiple sclerosis Italian patients: the GENIUS study
    Comi, Giancarlo
    Pozzilli, Carlo
    Morra, Vincenzo Brescia
    Bertolotto, Antonio
    Sangalli, Francesca
    Prosperini, Luca
    Carotenuto, Antonio
    Iaffaldano, Pietro
    Capobianco, Marco
    Colombo, Delia
    Nica, Mihaela
    Rizzoli, Sara
    Trojano, Maria
    NEUROLOGICAL SCIENCES, 2020, 41 (10) : 2843 - 2851
  • [4] Real-world effectiveness of fingolimod in Polish group of patients with relapsing-remitting multiple sclerosis
    Walczak, Agata
    Kurkowska-Jastrzebska, Iwona
    Zakrzewska-Pniewska, Beata
    Dorobek, Malgorzata
    Brola, Waldemar
    Zajdel, Radoslaw
    Bartosik-Psujek, Halina
    Stasiolek, Mariusz
    Kulakowska, Alma
    Rusek, Stanislaw
    Tutaj, Andrzej
    Glabinski, Andrzej
    Wlodek, Agata
    Kochanowski, Jan
    Ciach, Agnieszka
    Siger, Malgorzata
    Kurowska, Katarzyna
    Wicha, Wojciech
    Nojszewska, Monika
    Podlecka-Pietowska, Aleksandra
    Czajka, Anna
    Kapica-Topczewska, Katarzyna
    Bielecki, Bartosz
    Maciagowska-Terela, Marzena
    Stepien, Adam
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2019, 184
  • [5] The real-world effectiveness of natalizumab and fingolimod in relapsing-remitting multiple sclerosis. An Italian multicentre study
    Curti, Erica
    Tsantes, Elena
    Baldi, Eleonora
    Caniatti, Luisa Maria
    Ferraro, Diana
    Sola, Patrizia
    Granella, Franco
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 33 : 146 - 152
  • [6] Effectiveness of fingolimod in real-world relapsing-remitting multiple sclerosis Italian patients: the GENIUS study
    Giancarlo Comi
    Carlo Pozzilli
    Vincenzo Brescia Morra
    Antonio Bertolotto
    Francesca Sangalli
    Luca Prosperini
    Antonio Carotenuto
    Pietro Iaffaldano
    Marco Capobianco
    Delia Colombo
    Mihaela Nica
    Sara Rizzoli
    Maria Trojano
    Neurological Sciences, 2020, 41 : 2843 - 2851
  • [7] The real-world effectiveness and safety of fingolimod in relapsing-remitting multiple sclerosis patients: An observational study
    Izquierdo, Guillermo
    Damas, Fatima
    Dolores Paramo, Maria
    Luis Ruiz-Pena, Juan
    Navarro, Guillermo
    PLOS ONE, 2017, 12 (04):
  • [8] Real-world retrospective study of effectiveness and safety of FINgOlimod in relapsing remitting multiple sclerosis in the Middle East and North Africa (FINOMENA)
    Alroughani, Raed
    AlKawi, Zuhair
    Hassan, Ahmed
    Al Otaibi, Hessa
    Mujtaba, Ahmed
    Al Atat, Rami
    Riachi, Naji
    Akkawi, Nabil
    Koussa, Salam
    Inshasi, Jihad
    Alsaadi, Taoufik
    Ahmed, Samar Farouk
    Al-Aasmi, Abdullah
    Zakaria, Magd
    El Fadally, Haitham
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2021, 203
  • [9] REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal
    S. Batista
    C. C. Nunes
    J. J. Cerqueira
    Ana Martins Silva
    J. Correia de Sá
    J. Ferreira
    M. T. Mendonça
    J. Pinheiro
    V. Salgado
    A. S. Correia
    J. Sequeira
    A. Costa
    L. Sousa
    Neurological Sciences, 2021, 42 : 1995 - 2003
  • [10] Spanish real-world experience with fingolimod in relapsing-remitting multiple sclerosis patients: MS NEXT study
    Barrero, Francisco
    Mallada-Frechin, Javier
    Luisa Martinez-Gines, Maria
    Eugenia Marzo, Maria
    Meca-Lallana, Virginia
    Izquierdo, Guillermo
    Ramon Ara, Jose
    Oreja-Guevare, Celia
    Meca-Lallana, Jose
    Forero, Lucia
    Sanchez-Veram, Irene
    Jose Moreno, Maria
    PLOS ONE, 2020, 15 (04):
12345